Euan C. Ramsay

Ratiometric dosing of anticancer drug combinations: Controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice

Lawrence D. Mayer, Troy O. Harasym, Paul Tardi et al. · Molecular Cancer Therapeutics · 2006 · 324 citations · Full text

Liposomal Irinotecan

Corrie Lynn Messerer, Euan C. Ramsay, Dawn Waterhouse et al. · Clinical Cancer Research · 2004 · 81 citations · Full text

Microfluidic-Based Manufacture of siRNA-Lipid Nanoparticles for Therapeutic Applications

Colin Walsh, Kevin Ou, Nathan M. Belliveau et al. · Methods in molecular biology · 2014 · 54 citations

Nanoparticles, Nanomedicine, Engineering +5

Irinophore C: A Liposome Formulation of Irinotecan with Substantially Improved Therapeutic Efficacy against a Panel of Human Xenograft Tumors

Euan C. Ramsay, Malathi Anantha, Jason Zastre et al. · Clinical Cancer Research · 2008 · 41 citations · Full text

Decreased levels of hypoxic cells in gefitinib treated ER+ HER-2 overexpressing MCF-7 breast cancer tumors are associated with hyperactivation of the mTOR pathway: therapeutic implications for combination therapy with rapamycin

Wieslawa H. Dragowska, Maïté Verreault, Donald T. Yapp et al. · Breast Cancer Research and Treatment · 2007 · 17 citations

Breast Oncology, Medicine, Hypoxic Cells +9